American Heart Association http://www.heart.org
National Heart, Lung, and Blood Institute http://www.nhlbi.nih.gov
Heart and Stroke Foundation of Canada http://www.heartandstroke.ca
Health Canada http://www.hc-sc.gc.ca
Baigent C, Keech A, Kearney PM, et al. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Coronary artery disease (CAD). EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed. Updated January 13, 2015. Accessed March 26, 2015.
Douglas K, O'Malley PG, Jackson JL. Meta-analysis: the effect of statins on albuminuria.
Ann Intern Med.
Friis S, Poulsen AH, Johnsen SP, et al. Cancer risk among statin users: a population-based cohort study.
Int J Cancer.
Graaf MR, Beiderbeck AB, Egberts AC, et al. The risk of cancer in users of statins.
J Clin Oncol.
Ichihara A, Hayashi M, Ryuzaki M, et al. Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus.
Nephrol Dial Transplant.
Jick H, Zomberg GL, Jick SS, et al. Statins and the risk of dementia.
Kshirsagar AV, Shoham DA, Bang H, et al. The effect of cholesterol reduction with cholestyramine on renal function.
Am J Kidney Dis.
Statins. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed. Updated March 4, 2015. Accessed March 26, 2015.
Statins and cancer risk. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed. Updated June 13, 2014. Accessed March 26, 2015.
Statins for prevention of cardiovascular disease. EBSCO DynaMed website. Available at:
http://www.ebscohost.com/dynamed. Updated December 18, 2014. Accessed March 26, 2015.
Wolozin B, Kellman W, Rousseau P, et al. Decreased prevalence of Alzheimer's disease
associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.
1/30/2009 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
J Am Coll Cardiol.
3/6/2012 DynaMed's Systematic Literature Surveillance
http://www.ebscohost.com/dynamed: FDA announces safety changes in labeling for some cholesterol-lowering drugs. US Food and Drug Administration website. Available at:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm293623.htm. Published February 28, 2012. Accessed March 26, 2015.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © 2012 EBSCO Publishing
All rights reserved.
It's time to stop guessing. If you want to make some changes but just aren't sure how, the free personal health survey from LiveWell is a great place to start.
Fight heart disease and prevent heart attacks. HeartSHAPE® is a painless, non-invasive test that checks pictures of your heart for early-stage coronary disease.
How many calories do you need to eat each day to maintain your weight and fuel your physical activity? Enter a few of your stats into this calculator to find out.
Using body mass index as a reference, this calculator determines your ideal body weight range. All you need to do is enter your height.
This tool considers your height and weight to assess your weight status.
Wellmont Nurse Connection is your resource for valuable health information any time, 24 hours a day, seven days a week. Speak to a Nurse any time, day or night, at (423) 723-6877 or toll-free at 1-877-230-NURSE.
You clicked on a link that will cause you to leave myWellmont.
For security purposes you will be signed out.